ProfessorNick Lintzeris

Conjoint Professor Nicholas Lintzeris is a clinician researcher with over 35 years' experience working in the addiction medicine sector in clinical, teaching, policy and research roles. He became a Foundation Fellow of the Australasian Chapter of Addiction Medicine (FAChAM) and completed his PhD at the National Centre Epidemiology and Population Health at the Australian National University in 2002 and was awarded the NHMRC Neil Hamiliton Fairley Clinical Research Fellowship (2002-2006) which he completed at the National Addiction Centre, Kings College London, where he led the first RCT of heroin treatment for heroin dependence undertaken in the United Kingdom.

 

He has served as Chief Addiction Medicine Specialist for NSW Health (2012-14), Director of Drug and Alcohol Services at South Easter Sydney Local Health District (2010-2024), President of the Chapter of Addiction Medicine, Royal Australasian College Physicians (2020-22), Clinical Director of the Lambert initiative in Cannabinoid Therapeutics (University Sydney) (2014-16). He was the Foundation Chair (2017-21) of the Drug and Alcohol Clinical Research and Improvement Network (DACRIN), the only clinical research network in addiction medicine in Australia.

 

Prof NL's main career focus has been in the development, provision and research of innovative treatment for substance use disorders - particular focus on opioid dependence and cannabis dependence. He has been instrumental for many of the developments in Australia regrading buprenorphine treatment - including leading many clinical trials, training programs for health professionals, and authored national and state clinical guidelines regarding opioid dependence treatment. In recent years he has been at the forefront of medicinal cannabis research in the treatment of cannabis and other substances use disorders.

 

NL has also been instrumental in the development and implementation of routine clinical outcome monitoring in clinical practice in the AoD sector in Australia. He has led research in the development and refinement of the Australian Treatment Outcomes profile, the most widely used tool in Australia for this purpose, and for integrating this into routine care and electronic medical records systems across NSW. This work led to the development of Clinical Care Standards for the AoD sector across NSW.

 

NL has attracted over $55 million dollars of career research funding, including numerous NHMRC, MRFF, government, philanthropic and industry grants. He has authored over 270 peer review journal papers. He continues to practice clinically.